Timothy Allan Johnson

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Antibacterial Agents. Top assignees: Pfizer Corporation, Zoetis Services LLC, Genzyme Corporation. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy Allan Johnson. Retrieved from https://idiyas.com/inventor/timothy-allan-johnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 5)

% Patents Active = 47.4

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 47(Granted Patents)

Location History:

Greenwood, IN (US) (1999)
Howell, MI (US) (2009)
Kalamazoo, MI (US) (2015)
Richland, MI (US) (2014 - 2016)
Nope Hope, AL (US) (2017)
Bridgewater, NJ (US) (2022)
Cambridge, MA (US) (2022)
Vicksburg, MI (US) (2015 - 2024)

Company Filing History:

6. 1 out of 834,708

Other

patents

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

Antibacterial Agents

Fluoro-Pyridinone Phosphates

Boronates

Cell Viability

Bioreactor

Pyrrolo[2,3-D]Pyrimidine

Phenicol Antibacterials

Hydroxamic Acid Derivatives

Tricyclic Tetrahydroquinoline

Cephalosporins

Production Methods

Overhead Door Repair

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981696 - Fluoro-pyridinone phosphates and boronates useful as antibacterial agents (2024-05-14),

2. 11391725 - Methods for improving cell viability in a production bioreactor (2022-07-19),

3. 11306341 - Methods of culturing a mammalian cell (2022-04-19),

4. 9560371 - Video compression system (2017-01-31),

5. 9549929 - Pyrrolo[2,3-D]pyrimidine derivatives (2017-01-24),

6. 9545405 - Pyrrolo[2,3-D]pyrimidine derivatives (2017-01-17),

7. 9428528 - Phenicol antibacterials (2016-08-30),

8. 9422236 - Phenicol antibacterial agents (2016-08-23),

9. 9340564 - Phenicol antibacterials (2016-05-17),

10. 9340493 - Hydroxamic acid derivatives useful as antibacterial agents (2016-05-17),

11. 9206126 - Phenicol antibacterial agents (2015-12-08),

12. 9145355 - Phenicol antibacterials (2015-09-29),

13. 9073894 - Phenicol antibacterials (2015-07-07),

14. 9035074 - Pyrrolo[2,3-D]pyrimidine derivatives (2015-05-19),

15. 8952149 - Tricyclic tetrahydroquinoline antibacterial agents (2015-02-10),

Title: The Innovative Contributions of Timothy Allan Johnson

Introduction

Timothy Allan Johnson is a notable inventor based in Richland, MI (US), recognized for his significant contributions to the field of pharmaceuticals and biotechnology. With a remarkable portfolio of 19 patents, Johnson has made strides in developing innovative solutions aimed at improving health outcomes.

Latest Patents

Among his latest patents is the invention titled "Fluoro-pyridinone phosphates and boronates useful as antibacterial agents." This invention focuses on new fluoro-pyridinone hydroxamic acid phosphates and boronates, which serve as LpxC inhibitors to treat bacterial infections. Another significant patent is related to "Methods for improving cell viability in a production bioreactor." This patent outlines methods for predicting and enhancing cell viability in bioreactor settings, which is crucial for biopharmaceutical production.

Career Highlights

Throughout his career, Timothy Johnson has worked with prominent companies such as Pfizer Corporation and Zoetis Services LLC. His experience in these organizations has allowed him to apply his innovative ideas in real-world applications, contributing to advancements in medical science.

Collaborations

Johnson has collaborated with notable colleagues, including Richard Andrew Ewin and Matthew Frank Brown. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.

Conclusion

Timothy Allan Johnson's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving health through scientific advancements.

Profile summary based on public USPTO records.